Manage Your Liver
Q:

The threat of liver cancer remains despite successful HCV treatment

The threat of liver cancer remains despite successful HCV treatment
A:

Hepatocellular carcinoma (HCC) or liver cancer is currently the third leading cause of cancer deaths worldwide, affecting over 500,000 people. One of the major risks for the development of HCC is persistent infection with hepatitis C virus (HCV) and cirrhosis. Despite the recent development of direct-acting antivirals (DAAs), which has given hope to millions of liver disease patients around the world as they have made clearing the hepatitis C virus possible, the burden of HCC and cirrhosis caused by hepatitis C is likely to continue to grow.

 

Theoretically, the high success rates of DAAs now used to treat patients with HCV will lower the number of patients that would progress to cirrhosis and HCC. However, a study conducted by the University of Washington - School of Medicine predicted that the incidence of both cirrhosis and HCC are likely to continue to rise in the United States until 2021. [1] This is because DAAs are only designed to eradicate the virus; they do not help to restore liver health and normal liver function. Therefore even after successful DAA treatment, the damage that has occurred to the liver cannot be undone or wholly reversed without post treatment recovery care. People who have undergone treatment remain at elevated risk of HCC, especially those who have suffered many years of liver damage as a result of hepatitis C. The longer a patient has been infected with HCV, the greater the chance for abnormal liver cells to transform into cancer cells. [2]

 

This is supported by research, which has shown that a long-term risk for liver cancer remained in their study participants, even in some of those who have achieved sustained virological response (SVR). According to a clinical study, 5% of participants who achieved SVR subsequently developed liver cancer over an average observation period of five years. Moreover, among participants who did not experience SVR, cases of liver cancer were at least twice as high as among participants who did achieve SVR. [3]

 

In other words, achieving SVR does not indicate that damaged liver cells are healed and the risk of progression to HCC is relieved. Post-treatment regular monitoring and protective measures are needed to reduce the risk of developing tumours. To safeguard the liver from HCC, recovery of liver cells and long term protection is required. This can be achieved through YHK, a scientifically based natural liver therapy from Japan. Research has proven that it helps with the repair of damaged liver cells and regeneration of healthy liver cells. In addition, YHK has been shown to exert protective anti-tumour effect that helps to prevent liver cancer. Also, it has been scientifically proven to decrease the proliferation rate of human liver cancer cell growth and enhance the oxidative stress of liver cancer cells, which significantly increases apoptosis (programmed cell death). [4][5]

 

DAAs are no doubt a big step forward in the treatment of hepatitis C, but let’s not forget our ultimate aim and wish: ensuring liver health, good liver function, and preventing liver cancer.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
YHK users must be familiar with the beneficial effects of YHK, especially in bringing down elevated liver enzymes and its protective effect as anti-inflammatory, anti-fibrotic, and anti-oxidative properties. Our research shows that YHK contains several properties that demonstrate protective effects to the liver, and possible to bring down high ALT levels to the normal range in 4 weeks. What’s next after liver enzymes are normalized?   After the liver function re
A:
Liver has a natural regeneration power that allows itself to regrow to a normal size even after most of the part has been removed. While the exact type of liver cells that possess this repair power is still controversial, there is no doubt that this unique power is exclusive to the liver.   However, many exposures can damage the liver beyond the point of repair. In fact, a lot of people are suffered from liver problems. Around 1.5 billion cases of chronic liver proble
Hit Questions
A:
The liver carries out essential functions, including detoxifying harmful substances in your body, cleaning your blood and making new blood and other vital nutrients. Cirrhosis is scarring of the liver caused by long-term liver damage. The loss of liver cells turns into scar tissue which prevents the liver working normally, reducing or in some cases, completely losing liver function. Cirrhosis is a long-term chronic liver damage; it is often caused by chronic live
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
AST and ALT are two common markers for diagnosing liver diseases. Patients with liver disorders often find their AST and ALT levels unsatisfactory, but what do the figures actually imply? And do patients of every kind of liver dysfunctions have the same levels?   AST:ALT ratio Although the normal range of AST and ALT level varies among laboratories and countries, the ratio of AST:ALT is key when it comes to diagnosing liver diseases. The use
A:
ALT (Alanine Aminotransferase / SGPT) is a type of enzyme found in liver cells. When the liver cells are functioning normally, the ALT enzymes should be contained within the liver cells.    You can imagine each liver cells as a balloon, and the ALT enzymes are the air inside the balloon. When the balloon is damaged, the air will be released. And when the liver cells is damaged, ALT enzymes are released into the bloodstream, therefore we are able to find out the l
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us
Subscribe To Our Mailing List And
Never Miss Another Great Promotion!
Join our mailing list to receive latest new about our company, plus health articles. You will also be able to receive early bird discount from us!
Maybe Later, Thank you.
Subscribe success! You will receive latest new soon.